Table 3.
Base probabilitya | Cost ($)b | Utilityb | |
---|---|---|---|
Acute GU (first cycle) | |||
Acute GI Grade 2 toxicity | 0.1133 | 730.0746–48 | 0.786749 |
Acute GI Grade ≥3 toxicity | 0.0019 | 11,147.7946–48,50 | 0.50351,52 |
Acute GU Grade 2 toxicity | 0.2258 | 452.7947 | 0.798349 |
Acute GU Grade ≥3 toxicity | 0.0158 | 8,109.5047,53 | 0.4354,55 |
Chronic SE (cycles 2+) | |||
Chronic GI Grade 2 toxicity | 0.0117 | 730.0746–48 | 0.786749 |
Chronic GI Grade ≥3 toxicity | 0.0051 | 11,147.7946–48,50 | 0.50351,52 |
Chronic GU Grade 2 toxicity | 0.0178 | 452.7947 | 0.798349 |
Chronic GU Grade ≥3 toxicity | 0.0040 | 8,109.5047,53 | 0.4354,55 |
Recurrence (Biochemical) | 0.0229c | 14,011.7556,57 | 0.4958 |
Non-cancer death | 0.0397d | 0 | 0.00 |
Cancer death | 0.0036e | 0 | 0.00 |
GI, gastrointestinal;GU, genitourinary.
Base probabilities were obtained from averages in Table 2.
Full cost and utility breakdown is available in Appendix B.
A probability of 0.18 was used for recurrence to remain in the recurrence health state.59
Based on a 66 year old male with a 17.2 year life expectancy.18
A probability of 0.03 was used for recurrence to transition to the cancer death health state.60